Strain Availability
To request swine or cryopreserved material from the NSRRC, please contact NSRRC@missouri.edu, at (573) 882-1134.
There are a variety of samples available from the strains listed below: A few examples are fetal fibroblast, fresh and cryopreserved semen, live animals, hearts, femurs, kidneys, liver, Day 50 eyes, and Day 60 fetal hearts. Please inquire about the sample request and availability; we should be able to meet your requests in a timely manner. All NSRRC strain distributions require a NSRRC Outgoing Material Transfer Agreement.
List of Available Strains
| Stock # | Strain Name | Modification(s) | Gene(s) | Application(s) |
|---|---|---|---|---|
| NSRRC:0001 | Truline® Hampshire | none | wildtype | Background for genetic modification |
| NSRRC:0002 | Truline® Duroc | none | wildtype | Background for genetic modification |
| NSRRC:0003 | Truline® Landrace | none | wildtype | Background for genetic modification |
| NSRRC:0004 | Truline® Large White | none | wildtype | Background for genetic modification |
| NSRRC:0005 | Minnesota Mini | none | wildtype | Immune system ontogeny and regulation, xenotransplantation, xenoimmunotherapy of cancer |
| NSRRC:0008 | Ossabaw | none | wildtype | Background for genetic modification,obesity, diabetes, cardiovascular, Polycystic Ovarian Syndrome |
| NSRRC:0009 |
GGTA1KO/hDAF |
Transgenic Targeted Knock-Out | a-1,3-galactosyltransferase knockout; human decay-accelerating factor | Xenotransplantation research |
| NSRRC:0010 | GFP NT5 | transgenic | enhanced green fluorescent protein | Cell tracking |
| NSRRC:0011 | FAT-1 | transgenic | express a humanized Caenorhabditis elegans gene, fat-1, encoding an n-3 fatty acid desaturase | research in the areas of reproduction, cardiovascular, immune system, depression and cancer |
| NSRRC:0012 | Yucatan | none | wildtype | small porcine model as background for genetic modification |
| NSRRC:0013 | NIH Mini g/g | none | MHC SLA g/g | research in the areas of immune system, and xenotransplantation |
| NSRRC:0014 | NIH Mini c/c | none | MHC SLA c/c | research in the areas of immune system, and xenotransplantation |
| NSRRC:0015 | NIH Mini a/a | none | MHC SLA a/a | research in the areas of immune system, and xenotransplantation |
| NSRRC:0016 | GFP NT92 | transgenic | enhanced Green fluorescent Protein | Cell tracking |
| NSRRC:0017 | Rhodopsin | transgenic | Rhodopsin P23H substitution | Study of Retinitis Pigmentosa |
| NSRRC:0018 | FVIII | Tri-transgenic | Human coagulation factor VIII; Human alpha-antitrypsin; Propeptide cleavage enzyme (PACE) | Hemophilia Research |
| NSRRC:0019 | FIX | Tri-transgenic | Human coagulation factor IX; Human alpha-antitrypsin; von Willibrand factor | Hemophilia Research |
| NSRRC:0020 | GFP NT92-Yucatan | transgenic | enhanced Green fluorescent Protein | Cell Tracking |
| NSRRC:0021 | Tie2-eNOS | transgenic | endothelial Nitrate Oxide Synthase | Cardiovascular, Exercise Physiology |
| NSRRC:0022 | Tie2-Catalse | transgenic | Human Catalase | Cardiovascular, Exercise Physiology |
| NSRRC:0024 | GFP-Proteasomes | transgenic | GFP-Proteasome Fusion Protein |
Proteasome research |
NSRRC:0025 | Multi-Xeno | transgenic | a-1,3-galactosyltransferase knockout; human decay-accelerating factor (CD55); CD39; CD59 and thrombomodulin |
Xenotransplantation |
NSRRC:0026 | NLS-CAG-eGFP | transgenic | Nuclear localized signal-CAG- enhanced Green fluorescent Protein |
Cell Tracking |
NSRRC:0027 | CAG-Tomato | transgenic | CAG-Tomato |
Cell Tracking |
| NSRRC:0028 | Liver Suicide Genes | transgenic | Alpha fetoprotein promoter driving cytosine deaminase | Liver Research | NSRRC:0029 | Liver Suicide Genes | transgenic | Albumin promoter driving thymidine kinase | Liver Research |
PROCESS:
-
Receiving Investigator must:
- Fill out and submit an On-Line Receiving Investigator Application Form
- Provide a MTA (Material Transfer Agreement)
- Obtain authorization from the Receiving Investigator's Institution for animal shipment
- Ship animals to the Receiving Investigator's Institution
- Bill the account (see Distribution Fees)
The NSRRC will then:


